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We report a fairly special case of lymphocytic myocarditis progressing to a ﬁbrotic stage, described using multimodality imaging
and conﬁrmed on histopathology. This paper presents an uncommondiagnosis with a probable guarded prognosis.
1.Introduction
Myocarditis is a disease characterised by a polymorphic
clinical presentation and appears to be a major cause of
sudden, unexpected death in adults aged <40 years [1]. A
prominent lymphocytic inﬁltrate histologically characterizes
themajorityofbiopsy-veriﬁedmyocarditis.Wereportafairly
special case of an apparently lymphocytic myocarditis with
reparative ﬁbrosis, described using multimodality imaging
and conﬁrmed on histopathology.
2.CasePresentation
A 49-year-old farm laborer was referred to our hospital
with complete heart block, incidentally discovered when
he presented with persistent left sciatica despite analgesic
treatment. No personal or familial history except a smoking
habit was reported. The sciatica did not require immediate
surgicalmanagementaccordingtothephysicians’assessment
after a spinal magnetic resonance imaging. Electrocardio-
gram (Figure 1) revealed complete atrioventricular block
associated with atrial tachycardia. Thus, this patient was sent
to our intensive care unit for cardiac investigation. Clinical
history revealedNewYork Heart Association(NYHA)classII
dyspnea, associated with clinical signs of global heart failure.
Chest radiography demonstrated cardiomegaly and bilateral
hilar overload. Transthoracic echocardiography (Figure 2(a),
see Movie 1 Supplementary Material available online at
doi:10.1155/2011/740928)revealed extensive localized thick-
ening of the right ventricle, right atrium, interatrial septum,
and basal to mid interventricular septum associated with
a pericardial eﬀusion. The inﬁltration extended around
the root of the pulmonary artery and aorta (Figure 2(b),
Movie 2). Left ventricular systolic function was slightly
impaired (ejection fraction = 54%). Analysis of tissue
Doppler indices showed elevated left ventricular ﬁlling
pressures (E/E  ratio = 16.4). Blood sample tests found an
isolated inﬂammatory syndrome: C-Reactive Protein raised
to 50mg/L. Nt-proBNP increased to 1150pg/mL (N<
125pg/mL). Serological tests for a bacterial, fungal, or
immunological (including anti-nuclear antibodies, antineu-
trophil cytoplasmic antibodies, rheumatoid factor) cause
were negative. QuantiFERON-TB Gold test was negative,
and the angiotensin-converting enzyme level was normal.2 Case Reports in Medicine
I
II
III
II
aVR
aVL
aVF
V1
V2
V3
V4
V5
V6
Figure 1: Twelve-lead ECG demonstrating a complete atrioventricular block.
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Figure 2:Apicaltwo-dimensionalfour-chamber (a)echocardiogram showingmarkedthickeningoftherightventricle(arrow),rightatrium
(empty arrow), interatrial septum (empty arrowhead), and basal to mid interventricular septum (arrowhead) associated with a pericardial
eﬀusion. Aortic valve short-axis view (b) demonstrating that the thickened tissue (asterisk) extends around the root of aorta. RA indicates
right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; AV, aortic valve.
Cardiovascular magnetic resonance (CMR) imaging was
performed to localize and characterize the nature of the
tissue thickening. Four-chamber (Figure 3(c),M o v i e3 ) ,
apical short-axis, and long-axis (Movie 4) cine images were
performed using steady-state free precession (SSFP) cine
sequences. The right ventricular wall was akinetic, with
preservation of apical contractility. Short-axis dark-blood
T2-weighted (Figures 3(a) and 3(b)) sequences conﬁrmed
concentric thickening and oedema of the right ventri-
cle. First-pass perfusion (Figure 3(d), Movie 5) showed
enhancement of the right ventricular and interventricular
septum inﬁltration consistent with an active inﬂammatory
process. Delayed enhancement CMR (Figures 3(e) and
3(f)) sequences demonstrated widespread and heteroge-
neous enhancement of the right ventricle. Combined (18)F-
ﬂuoro-2-deoxyglucose positron emission tomography (FDG
PET)/computed tomography (CT) was performed to look
for primary malignant lesion (Figure 4)s h o w i n gm o d e r a t e
FDGuptakeinvolvingmainly therightheart chambers ofthe
heart. This whole body exam did not detect any extracardiac
locations of FDG uptake.
The patient was treated with diuretics, angiotensin-
converting enzyme inhibitors, spironolactone, amiodarone,
and adequate anticoagulation (INR 2.0-3.0) with warfarin
associated with steroid therapy (prednisolone 1mg/kg/day).
Right ventricular myocardial biopsy and implantation of
a dual-chamber epicardial pacemaker were performed via
a sternal thoracotomy. Hematoxylin-eosin-saﬀron stained
sections of the tissue sample showed a granulomatous
reaction consisting of nodular cellular inﬁltrates (histiocytes
associated with lymphocytic elements) with an abundant
ﬁbrotic reaction (Figures 5(a) and 5(b)). Immunohisto-
chemistry revealed a prevalence of T lymphocytes (CD3
positive; Figure 5(c)) mixed with B lymphocytes (CD20
positive), histiocytes (CD68 positive; Figure 5(d))a n da
few plasma cells (CD138 positive). Neither giant cells norCase Reports in Medicine 3
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Figure 3: T2-weighted short inversion-time, inversion-recovery (STIR) breath hold pulse sequences ((a) and (b)) showing concentric
thickening and oedema of the right ventricle. The inﬁltration (asterisk) extends around the root of the pulmonary artery. Four-chamber
SSFP cine view (c) showing inﬁltration of the right ventricle (arrow), right atrium (empty arrow), interatrial septum (empty arrowhead),
andbasalto midinterventricular septum (arrowhead).Four-chamber ﬁrst-pass T1-weighted multishotgradient-echo echo-planar sequence
(d) shows partial hyperenhancement (arrow) of the right ventricle in support of an inﬂammatory process. Four-chamber (e) and short-axis
(f) three-dimensional phase-sensitive inversion recovery sequences demonstrating widespread and heterogeneous enhancement (#) of the
right atrium and ventricle. RA indicates right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; PV, pulmonary valve.
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Figure 4: FDG-PET in the transaxialplane shows moderate FDG uptake (arrows) involving mainly the right heart.4 Case Reports in Medicine
(a) (b)
(c) (d)
Figure 5: Low (a) and high (b) magniﬁcations of hematoxylin-eosin-safron stained sections showing nodular cellular inﬁltrates with
abundantﬁbrosis;immunohistochemistryrevealingaprevalenceofCD3-positiveTlymphocytes (c)andsomeCD68-positivehistiocytes(d).
epithelioid cells were observed, thus rejecting the diagnoses
of giant cell myocarditis and cardiac sarcoidosis. Vessels were
not speciﬁcally concerned with the cellular inﬁltrates, so that
a diagnosis of vasculitis was also excluded. Congo red and
hematoxylin-eosin stained sections did not show amyloid
deposits. Nested/reverse transcription-PCR did not detect
any genomes of enterovirus, adenovirus, parvovirus B19, or
human herpes virus type 6.
At followup twelve months later, the patient described
NYHA class II dyspnea, with no clinical signs of heart
failure. Echocardiography revealed persistent myocardial
inﬁltration, although the pericardial eﬀusion had resolved.
The patient remained pacemakerdependentwith underlying
complete heart block, which is probably the consequence of
inﬁltration of the cardiac conduction system with granulo-
matous tissue. Nt-proBNP had decreased to 550pg/mL.
3.Discussion
We report a fairly special case of lymphocytic myocarditis
progressing to a ﬁbrotic stage, described using multi-
modality imaging and conﬁrmed on histopathology. This
paper presents an uncommon diagnosis with a probable
guarded prognosis.
First, although MRI and other imaging modalities ﬁnd-
ings are relatively nonspeciﬁc, we can notice the ability of
dark-blood T2-weighted and ﬁrst-pass perfusion imaging
to detect, respectively, oedema and enhancement of the
right ventricular free wall and the interventricular septum
inﬁltration consistent with an active inﬂammatory pro-
cess. Consequently, we decided a corticosteroid therapy in
order to clear inﬂammation. Furthermore, we conﬁrm in
this paper CMR’s ability to depict myocardial ﬁbrosis on
delayed enhancement imaging. We can suppose that this
ﬁbrous inﬁltration of the right ventricle and basal to mid
interventricular septum is responsible for the persistence of
conduction disturbances. Thus, cardiac magnetic resonance
imaging detected oedema, residual inﬂammatory process,
and myocardial ﬁbrosis, which may inﬂuence patient’s
management.WeregretthatasecondCMRcontrolcouldnot
be performed because of the pacemaker.
Secondly, this patient presented incidentally with appar-
ently idiopathic cardiac granulomatosis, probably being
longstanding. We used the term “granulomatous” because
of the nature of nodular lesions and the presence of
histiocytes associated with lymphocytic elements. Cardiac
sarcoidosis and idiopathic giant cell myocarditis are usually
clinicopathologicentities evocatedin this situation. Okura et
al. [2] demonstrated, in a large series of patients, histological
diﬀerences between cardiac sarcoidosis and idiopathic giant
cell myocarditis: the ﬁrst has more granulomas and ﬁbrosis,
while the second one more necrosis, foci of lymphocytic
myocarditis and eosinophils. The number of giant cells
is equivalent in the two entities. Presentation with heartCase Reports in Medicine 5
failure predicted idiopathic giant cell myocarditis, whereas
presentation with heart block or more than nine weeks
of symptoms is associated with cardiac sarcoidosis. There
is still an open debate as to whether idiopathic giant cell
myocarditis and cardiac sarcoidosis are separate disorders.
However, in this case, neither giant cells nor epithelioid cells
were observed, thus rejecting the diagnoses of giant cell
myocarditis and cardiac sarcoidosis. Thus, a viral-negative
lymphocytic myocarditis which had progressed to a ﬁbrotic
and granulomatous stage was the most plausible diagnosis,
although we recognize that inﬁltration of the aortic root and
the right atrium is very unusual in case of myocarditis. Sur-
prisingly, in this patient presenting with chronic myocarditis
and persistent inﬂammation, nested/reverse transcription-
PCR did no detect any genomes of virus. Gutberlet et al.
[3] observed that viral genomes were ampliﬁed at nested
PCR assay in 49 (59%) of the 83 patients presenting
with chronic myocarditis. Parvovirus B19 was the most
frequently detected virus. Because lymphocytic myocarditis
has multiple etiologies, therapy should be individualized
according to the speciﬁc etiology. Unfortunately, eﬃcacy
of most therapies used or proposed for use in lympho-
cytic myocarditis has not been proven. Until this proof is
available, speciﬁc and nonspeciﬁc antiviral measures should
be considered for use in those patients who present with
documented ongoing viral infection. Likewise, appropriate
antimicrobial is always indicated in lymphocytic myocarditis
caused by bacterial and other organisms. The area of
greatest controversy is the use of immunosuppressive and
other immunomodulatory therapies for noninfectious and
postinfectious myocarditis. In our case we hypothesize
that corticosteroid therapy may be eﬀective in clearing
the residual inﬂammatory process. Healing of myocarditis
lesions may result in some degrees of ﬁbrosis [4–6]. Earlier
series have shown that symptoms do not reﬂect the extent
of lymphocytic inﬁltrate and ﬁbrosis [7]. However, we can
notice that our patient presented with severe heart failure,
andinparallel theendomyocardialbiopsyshowedsigniﬁcant
ﬁbrosis.
Thirdly, this paper presents an uncommon diagnosis
with a probable guarded prognosis. Magnani et al. [8]
reported in 112 patients with histopathologic conﬁrmation
of myocarditis that 88 (79%) and 63 (56%) were alive
without cardiac transplantation at 1 and 5 years, respectively.
Furthermore, Davidoﬀ et al. [5] observed that the presence
of atrioventricular block requiring pacemaker insertion was
predictive of a subsequent fatal outcome in both giant cell
and lymphocytic myocarditis.
4.Conclusion
We report a fairly special case of lymphocytic myocarditis
progressing to a ﬁbrotic stage, described using multi-
modality imaging and conﬁrmed on histopathology. The
combination of CMR with various image acquisition
sequencesassociated with other imaging modalities provides
a noninvasive morphological assessment and tissue charac-
terization of myocardial involvement. This paper presents an
uncommon diagnosis with a probable guarded prognosis.
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